Nutex Health Inc (NASDAQ: NUTX) started the day on Thursday, with a price increase of 8.85% at $149.00, before settling in for the price of $136.89 at the close. Taking a more long-term approach, NUTX posted a 52-week range of $4.16-$142.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 4178.64% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.97%. This publicly-traded company’s shares outstanding now amounts to $5.51 million, simultaneously with a float of $3.32 million. The organization now has a market capitalization sitting at $823.74 million. At the time of writing, stock’s 50-day Moving Average stood at $67.52, while the 200-day Moving Average is $35.11.
Nutex Health Inc (NUTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Care Facilities Industry. Nutex Health Inc’s current insider ownership accounts for 40.00%, in contrast to 16.45% institutional ownership. According to the most recent insider trade that took place on Apr 08 ’25, this organization’s Chief Financial Officer bought 1,000 shares at the rate of 81.81, making the entire transaction reach 81,810 in total value, affecting insider ownership by 4,888. Preceding that transaction, on Aug 22 ’24, Company’s Chief Financial Officer bought 1,350 for 21.46, making the whole transaction’s value amount to 28,970. This particular insider is now the holder of 2,277 in total.
Nutex Health Inc (NUTX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.81 per share during the current fiscal year.
Nutex Health Inc’s EPS decrease for this current 12-month fiscal period is -6.97% and is forecasted to reach 8.37 in the upcoming year.
Nutex Health Inc (NASDAQ: NUTX) Trading Performance Indicators
Let’s observe the current performance indicators for Nutex Health Inc (NUTX). It’s Quick Ratio in the last reported quarter now stands at 2.06. The Stock has managed to achieve an average true range (ATR) of 11.73. Alongside those numbers, its PE Ratio stands at $16.07, and its Beta score is -0.91. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.72. Similarly, its price to free cash flow for trailing twelve months is now 39.51.
In the same vein, NUTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 9.27, a figure that is expected to reach 2.70 in the next quarter, and analysts are predicting that it will be 8.37 at the market close of one year from today.
Technical Analysis of Nutex Health Inc (NUTX)
If we take a close look at the recent performances of Nutex Health Inc (NASDAQ: NUTX), its last 5-days Average volume was 0.18 million that shows progress from its year to date volume of 65952.0. During the previous 9 days, stock’s Stochastic %D was recorded 95.08% While, its Average True Range was 13.75.
Raw Stochastic average of Nutex Health Inc (NUTX) in the period of the previous 100 days is set at 98.13%, which indicates a major rise in contrast to 97.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 187.19% that was higher than 118.19% volatility it exhibited in the past 100-days period.
